The Advisory Committee for Immunization Practices (ACIP) voted to recommend the use of Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine (MenHibrix, GlaxoSmithKline) in infants at increased risk for bacterial meningitis.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

ACIP recommends bacterial meningitis vaccine for at-risk infants

Newsletter